Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol

Autor: C. Anholm, P. Kumarathurai, M. S. Klit, O. P. Kristiansen, O. W. Nielsen, S. Ladelund, S. Madsbad, A. Sajadieh, S. B. Haugaard, C. Lange, J. J. Holst, J. Molvig, C. Deacon, M. Fenger, O. Andersen, R. Boston

Publikováno v: BMJ Open

Introduction Newly diagnosed type 2 diabetes mellitus (T2DM) in patients with coronary artery disease (CAD) more than doubles the risk of death compared with otherwise matched glucose tolerant patients. The biguanide metformin is the drug of choice i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5002ff2b558b3796e85b46a0fd9262a1
https://pubmed.ncbi.nlm.nih.gov/25031198

Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial.

Autor: Pedersen LR; Department of Cardiology, Bispebjerg University Hospital, University of Copenhagen, Building 67, 1st, Bispebjerg Bakke 23, 2400, Copenhagen, NW, Denmark. lrpedersen@gmail.com.; Department of Cardiology, University Hospital of Zealand, Roskilde, University of Copenhagen, Copenhagen, Denmark. lrpedersen@gmail.com., Olsen RH; Department of Cardiology, Bispebjerg University Hospital, University of Copenhagen, Building 67, 1st, Bispebjerg Bakke 23, 2400, Copenhagen, NW, Denmark., Anholm C; Department of Internal Medicine, Glostrup University Hospital, University of Copenhagen, Copenhagen, Denmark., Astrup A; Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark., Eugen-Olsen J; Clinical Research Centre, Hvidovre University Hospital, University of Copenhagen, Copenhagen, Denmark., Fenger M; Department of Medical Biochemistry, Genetics and Molecular Biochemistry, Hvidovre University Hospital, University of Copenhagen, Copenhagen, Denmark., Simonsen L; Department of Clinical Physiology and Nuclear Medicine, Bispebjerg University Hospital, University of Copenhagen, Copenhagen, Denmark., Walzem RL; Faculty of Nutrition, Texas A & M University, College Station, TX, USA., Haugaard SB; Department of Internal Medicine, Amager and Hvidovre University Hospital, University of Copenhagen, Copenhagen, Denmark., Prescott E; Department of Cardiology, Bispebjerg University Hospital, University of Copenhagen, Building 67, 1st, Bispebjerg Bakke 23, 2400, Copenhagen, NW, Denmark.

Publikováno v: Cardiovascular diabetology [Cardiovasc Diabetol] 2019 Oct 01; Vol. 18 (1), pp. 127. Date of Electronic Publication: 2019 Oct 01.

Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.

Autor: Anholm C; Department of Internal Medicine, Copenhagen University Hospital, Glostrup, Denmark.; Department of Internal Medicine, Copenhagen University Hospital, Amager, Denmark., Kumarathurai P; Department of Cardiology, Copenhagen University Hospital, Bispebjerg, Denmark., Samkani A; Department of Endocrinology, Copenhagen University Hospital, Bispebjerg, Denmark., Pedersen LR; Department of Cardiology, Copenhagen University Hospital, Bispebjerg, Denmark., Boston RC; Departments of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, Australia., Nielsen OW; Department of Cardiology, Copenhagen University Hospital, Bispebjerg, Denmark., Kristiansen OP; Department of Cardiology, Copenhagen University Hospital, Bispebjerg, Denmark., Fenger M; Department of Clinical Biochemistry, Copenhagen University Hospital, Hvidovre, Denmark., Madsbad S; Department of Endocrinology, Copenhagen University Hospital, Hvidovre, Denmark., Sajadieh A; Department of Cardiology, Copenhagen University Hospital, Bispebjerg, Denmark., Haugaard SB; Department of Internal Medicine, Copenhagen University Hospital, Amager, Denmark.; Department of Endocrinology, Copenhagen University Hospital, Bispebjerg, Denmark.; Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 Aug; Vol. 21 (8), pp. 2012-2016. Date of Electronic Publication: 2019 May 29.

The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial.

Autor: Samkani A; Department of Endocrinology, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, 2400, Copenhagen, NV, Denmark. amsam03@gmail.com., Skytte MJ; Department of Endocrinology, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, 2400, Copenhagen, NV, Denmark., Anholm C; Department of Internal Medicine, Copenhagen University Hospital, Glostrup, Denmark., Astrup A; Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark., Deacon CF; Endocrinology Research Section, Department of Biomedical Sciences, Copenhagen, Denmark.; Section for Translational Physiology, Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark., Holst JJ; Endocrinology Research Section, Department of Biomedical Sciences, Copenhagen, Denmark.; Section for Translational Physiology, Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark., Madsbad S; Department of Endocrinology, Copenhagen University Hospital, Amager Hvidovre, Copenhagen, Denmark., Boston R; School of Medicine, Department of Medicine, University of Melbourne, Melbourne, Australia., Krarup T; Department of Endocrinology, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, 2400, Copenhagen, NV, Denmark., Haugaard SB; Department of Endocrinology, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, 2400, Copenhagen, NV, Denmark.; Department of Internal Medicine, Copenhagen University Hospital, Amager Hvidovre, Copenhagen, Denmark.

Publikováno v: Lipids in health and disease [Lipids Health Dis] 2018 Dec 27; Vol. 17 (1), pp. 295. Date of Electronic Publication: 2018 Dec 27.

Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study.

Autor: Kumarathurai P; aDepartment of Cardiology, Copenhagen University Hospital of Bispebjerg bDepartment of Internal Medicine, Copenhagen University Hospital of Amager cDepartment of Endocrinology, Copenhagen University Hospital of Hvidovre dClinical Research Center, Copenhagen University Hospital of Hvidovre, Copenhagen, Denmark., Anholm C, Fabricius-Bjerre A, Nielsen OW, Kristiansen O, Madsbad S, Haugaard SB, Sajadieh A

Publikováno v: Journal of hypertension [J Hypertens] 2017 May; Vol. 35 (5), pp. 1070-1078.